Frontiers in Immunology (Mar 2022)
Corrigendum: Endothelin-A Receptor Antagonist Alleviates Allergic Airway Inflammation via the Inhibition of ILC2 Function
- Xiaogang Zhang,
- Ziyang Chen,
- Shaowen Zuo,
- Hengbiao Sun,
- Xinyao Li,
- Xiao Lu,
- Zhe Xing,
- Meiqi Chen,
- Jingping Liu,
- Gang Xiao,
- Yumei He,
- Yumei He,
- Yumei He
Affiliations
- Xiaogang Zhang
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Ziyang Chen
- Department of Neurosurgery Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China
- Shaowen Zuo
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Hengbiao Sun
- Department of Clinical Laboratory, The Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, China
- Xinyao Li
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Xiao Lu
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Zhe Xing
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Meiqi Chen
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Jingping Liu
- Department of Clinical Laboratory, The Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, China
- Gang Xiao
- Department of Clinical Laboratory, The Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, China
- Yumei He
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Yumei He
- Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Southern Medical University, Guangzhou, China
- Yumei He
- Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China
- DOI
- https://doi.org/10.3389/fimmu.2022.877694
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
- endothelin-A receptor antagonist
- BQ123
- therapeutic
- allergic airway inflammation
- group 2 innate lymphoid cell